About
3.16USD-0.02 -0.63%
Closed • Updated at 00:56 GMT+00:00Market Cap$16.89M
Volume11.6K
Beta2.66
RSI48.01
Newcelx Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
Apr 20 2026
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Apr 1 2026
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Mar 9 2026
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
Feb 12 2026
NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy
Community Chat
Ask AI
Try asking
Translate